Table 2.
Predictive Factors for Complete Response
| Variable | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| HR | 95% Cl | p-value | HR | 95% Cl | p-value | |
| Age (>60 yr) | 0.805 | 0.520–1.245 | 0.330 | |||
| Male sex | 1.404 | 0.888–2.221 | 0.146 | |||
| HBV | 1.171 | 0.668–2.053 | 0.582 | |||
| HCV | 0.655 | 0.363–1.183 | 0.161 | |||
| Liver cirrhosis | 1.759 | 0.953–3.248 | 0.071 | |||
| MELD score (>10) | 0.931 | 0.429–2.022 | 0.857 | |||
| CTP score (A/B, C) | 1.057 | 0.666–1.678 | 0.815 | |||
| AFP (>20 ng/mL) | 1.709 | 1.101–2.650 | 0.017 | |||
| Tumor size (>5 cm) | 3.441 | 1.775–6.673 | <0.001 | 2.840 | 1.449–5.565 | 0.002 |
| Nodularity (multinodular) | 2.658 | 1.687–4.187 | <0.001 | 2.435 | 1.535–3.861 | <0.001 |
| Portal vein thrombosis | 3.562 | 1.303–9.739 | 0.013 | |||
HR, hazard ratio; CI, confidence interval; HBV, hepatitis B virus; HCV, hepatitis C virus; MELD, model for end-stage liver disease; CTP, Child-Turcotte-Pugh; AFP, α-fetoprotein.